Clinical Trial Update: A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of once-weekly exenatide in Japanese adults with Type 2 diabetes. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bydureon (exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED